Publication | Closed Access

Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze

Psychoactive DrugBehavioral NeuroscienceNeurophysiologyMedicineBehavioral PharmacologyBehavioural PharmacologyPsychopharmacologyNeuropharmacologyBehavioral EffectsBasolateral AmygdalaNeuroscienceRitanserin MicroinfusionPharmacologyNeurochemistrySocial Sciences